Invesco Private Capital - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 21 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Private Capital ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$41,000
-88.4%
58,158
-50.0%
0.01%
-84.8%
Q3 2014$354,000
-0.8%
116,3160.0%0.03%
+17.9%
Q2 2014$357,000
-16.6%
116,3160.0%0.03%
-3.4%
Q1 2014$428,000
-8.5%
116,3160.0%0.03%
-6.5%
Q4 2013$468,000
-5.6%
116,3160.0%0.03%
-41.5%
Q3 2013$496,000
+44.6%
116,3160.0%0.05%
+51.4%
Q2 2013$343,000116,3160.04%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,356,091$1,202,0000.05%
VANGUARD GROUP INC 6,177,466$156,921,0000.01%
SHUFRO ROSE & CO LLC 17,500$8,0000.00%
LEAVELL INVESTMENT MANAGEMENT, INC. 12,000$6,0000.00%
PACIFIC GLOBAL INVESTMENT MANAGEMENT CO 10,000$5,0000.00%
Glassman Wealth Services 2,197$1,0000.00%
Krilogy Financial LLC 600$1,0000.00%
BANK OF AMERICA CORP /DE/ 5,856$3,0000.00%
NORTHERN TRUST CORP 33,166$17,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 86,435$44,0000.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders